Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
abrdn Life Sciences Investors
About HQL
abrdn Life Sciences Investors (the Fund) is a non-diversified closed-end management investment company. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in equity and related securities of the United States and foreign companies principally engaged in the development, production or distribution of products or services related to scientific advances in life sciences (including biotechnology, pharmaceuticals, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices, supplies and other healthcare-related sub-sectors), agriculture and environmental management (Life Sciences Companies). The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded primarily in foreign markets. The Fund’s investment adviser is abrdn Inc.
Find out what a historical investment in abrdn Life Sciences Investors would be worth today using our HQL stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
11.85%
Volume
74.21K
High today
$17.46
Low today
$17.22
Open price
$17.23
52-week high
$18.46
52-week low
$12.12
Ready to start your investing journey with Stake?
Open an accountHow do I buy HQL shares in Australia?
Buying HQL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in abrdn Life Sciences Investors in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in HQL
What is the ticker symbol of abrdn Life Sciences Investors?
The ticker symbol for abrdn Life Sciences Investors is HQL.
How much is one share of HQL?
One share of HQL is valued at $17.30 as of 22 May 2026.
Does HQL pay dividends?
Yes, HQL does pay dividends.
What is the dividend yield for HQL?
The dividend yield for HQL is 11.85% as of 22 May 2026.
What is the P/E ratio of HQL?
The Price to Earnings ratio of HQL is 6.27.
What is the Earnings Per Share of HQL?
The Earnings Per Share of HQL is $2.74.
What is the 52-week high for abrdn Life Sciences Investors stock?
The abrdn Life Sciences Investors 52-week high stock price is $18.46.
What is the 52-week low for abrdn Life Sciences Investors stock?
The abrdn Life Sciences Investors 52-week low stock price is $12.12.
Can I buy HQL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy HQL shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in HQL on Stake
- Buy HQL from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of HQL from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
HQL related stocks